Material Safety Data Sheet
MSDS-09588-0-001
E
Rev.:
CIDEX ?OPA Solution
Product:
Issue Date: 6-28-05
1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE
COMPANY/UNDERTAKING
Supplier:
Advanced Sterilization Products
33 Technology Drive
Irvine, CA 92618
1-800-755-5900
Customer service telephone:
1-877-208-6653 24 hrs
Emergency telephone number:
CIDEX OPA Solution
Product name:
None
Synonyms:
2. COMPOSITION/INFORMATION ON INGREDIENTS
The ingredients at their given percentages in this product are not considered hazardous to your health.
Components CAS Number Weight % J&J - OEL Data J&J - OEL Data J&J - OEL Data J&J - PBOEL
(TWA - 8 hr) (STEL): (Ceiling Limit
Value):
ortho-Phthalaldehyde 643-79-8 <1 Not Determined Not Determined Not Determined Not Determined
(1,2 ?benzenedicarboxaldehyde)
3. HAZARDS IDENTIFICATION
May cause eye, skin and respiratory irritation.
Emergency overview:
May elicit an allergic reaction.
CIDEX OPA Solution has been reported to cause anaphylactic-like reactions in
bladder cancer patients undergoing repeated cystoscopy.
CIDEX OPA Solution should not be used to reprocess instruments for patients that
have shown previous sensitivity to this solution or any of its ingredients.
May cause sensitization by repeated skin contact.
Properties affecting health:
Principle routes of exposure:
Not anticipated to be a significant route of occupational exposure.
Oral:
May cause eye irritation and redness.
Eye contact:
May cause skin irritation. Repeated exposure may cause skin dryness or cracking.
Skin contact:
Exposure to skin may cause temporary staining.
Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhea.
Ingestion:
Exposure can irritate and discolor the tissues of the mouth, esophagus and other
tissues of the digestive tract.
Company: ADVANCED STERLIZATION PRODUCTS Product code: ASPOPA
Product name: CIDEX?OPA Solution CO-12305-2
Page 1 of 7
May cause irritation, including but not limited to discharge, coughing, wheezing
Inhalation:
tightness of chest and throat, difficulty breathing and stinging sensation in nose and
throat, tingling of mouth and lips, headache, lose of smell and dry mouth. Symptoms
are temporary and reversible.
Hazard information:
None
Target organ effects:
Not a reproductive effector.
Reproductive effects:
Not mutagenic in the Ames assay.
Mutagenic effects:
May cause sensitization.
Sensitization:
Carcinogenicity rating:
Components CAS Number NTP: IARC: California
J & J:
Proposition 65 List:
ortho-Phthalaldehyde 643-79-8 Not Determined Not Determined Not Determined Not Determined
(1,2 ?benzenedicarboxaldehyde)
None.
Signs and symptoms:
Inhalation of vapor may cause asthma-like symptoms (chest discomfort and
Medical conditions
tightness, difficulty with breathing) as well as aggravate pre-existing asthma.
aggravated by exposure:
4. FIRST AID MEASURES
In the case of contact with eyes, rinse immediately with plenty of water for 15
Eye contact:
minutes and seek medical attention.
Do not induce vomiting. Rinse mouth followed by drinking a large quantity of water
Ingestion:
Move to fresh air immediately. If experiencing difficulty breathing, seek medical
Inhalation:
attention.
Wash contaminated areas thoroughly with soap and water.
Skin contact:
Remove contaminated clothing and wash before re-use.
Seek medical attention if irritation develops or persists.
None.
Protection of first-aiders:
Probable damage to the mucosa from oral exposure may contraindicate the use of
Notes to physician:
gastric lavage.
Company: ADVANCED STERLIZATION PRODUCTS Product code: ASPOPA
Product name: CIDEX?OPA Solution CO-12305-2
Page 2 of 7
5. FIRE-FIGHTING MEASURES
Not applicable
Flash point (癋):
Not applicable
Flash point (癈):
Not applicable
Autoignition temperature:
Not applicable
Flammable limits in air - lower (%):
Health: 1 flammability: 0 reactivity: 0
NFPA rating:
HMIS/ NFPA rating and classification:
Fire fighting information:
Use any extinguishing agent which is suitable for the
Suitable extinguishing media:
surrounding fire
Extinguishing media which must not be used for
None
safety reasons:
None
Specific methods:
Wear self-contained breathing apparatus for fire fighting if
Special protective equipment for firefighters:
necessary.
None
Hazardous combustion products:
None
Explosivity:
Explosion limits:
None
lower:
None
upper:
6. ACCIDENTAL RELEASE MEASURES
Wear eye and skin protection while handling material for clean-up.
Personal precautions:
Avoid breathing vapors and/or mists.
Do not wash down sewers or waterways.
Environmental precautions:
If required, neutralize by sprinkling approximately 25 grams of glycine (CAS# 56-40-
Methods for cleaning up:
6) powder per gallon of CIDEX OPA Solution spill. Thoroughly blend the glycine into
the spill using mop or other tools. Allow 5 minutes contact for neutralization.
Pick up and transfer to properly labeled containers. Allow neutralization to continue
for 1 hour and then dispose of in accordance with all applicable federal, state, and
local regulations.
Clean contaminated surface thoroughly.
Company: ADVANCED STERLIZATION PRODUCTS Product code: ASPOPA
Product name: CIDEX?OPA Solution CO-12305-2
Page 3 of 7
7. HANDLING AND STORAGE
Handling:
Use in well ventilated area and use with appropriate exhaust
Technical measures/precautions:
ventilation, for example a minimum of 10 air exchanges per
hour or as defined by state and local regulations.
Wear appropriate personal protection. Avoid contact with
Safe handling advice:
skin, eyes and clothing. Remove contaminated clothing and
launder before reuse.
Storage:
This product should be stored between 59癋 (15癈) and
Technical measures/storage conditions:
86癋 (30癈)
Keep containers tightly closed.
Avoid contact with strong acids and bases. Keep from
Incompatible products:
contact with oxidizing materials.
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Ensure adequate ventilation.
Engineering controls:
Eye protection recommended.
Eye protection:
Chemical resistant gloves recommended.
Hand protection:
Wear suitable protective clothing.
Skin and body protection
None required.
Respiratory protection:
None required.
Other/general protection:
9. PHYSICAL AND CHEMICAL PROPERTIES
Clear liquid
Appearance:
Liquid
Physical state:
Light blue
Color:
7.2-7.8
pH:
Slight Odor
Odor:
212
Boiling temperature (篎):
100
Boiling temperature (篊):
0
Freezing point/range (篊):
32
Freezing point/range (篎):
1.0003g/cc
Specific gravity:
similar to water
Evaporation rate:
soluble
Water solubility:
10. STABILITY AND REACTIVITY
Stable under recommended storage conditions.
Chemical stability:
Hazardous polymerization does not occur.
Hazardous polymerization:
Unknown on product.
Hazardous decomposition products:
Company: ADVANCED STERLIZATION PRODUCTS Product code: ASPOPA
Product name: CIDEX?OPA Solution CO-12305-2
Page 4 of 7
Strong acids and strong bases.
Materials to avoid:
Stay away from strong oxidizing agents.
Extremes of temperature and direct sunlight.
Conditions to avoid:
11. TOXICOLOGICAL INFORMATION
Acute toxicity
>5000 mg/kg
LD50/oral/rat (mg/kg) =
>2000 mg/kg
LD50 Dermal Rabbit (mg/kg):
Local effects
Non-toxic
Oral:
May cause eye irritation.
Eye irritation
May cause skin irritation.
Skin irritation:
Unknown on product.
Inhalation:
Chronic toxicity
Unknown on product.
Oral:
Unknown on product.
Inhalation:
Unknown on product.
Dermal:
Subchronic toxicity
Oral administration of o-phthalaldehyde to rats for 90 days resulted in a NOEL of
Oral:
5mg/kg/day.
Unknown on product.
Dermal:
Specific effects
Not corrosive.
Corrosive effects:
May elicit an allergic reaction.
Sensitization:
None
Target organ effects:
Not mutagenic in Ames test.
Mutagenic effects:
Unknown on product.
Reproductive effects:
Oral administration of o-phthalaldehyde to pregnant rats indicated that at maternally
Developmental effects:
non-toxic doses (less than 10 mg/kg/day) there was no developmental effect.
Unknown on product.
Carcinogenic effects:
12. ECOLOGICAL INFORMATION
Ecotoxicity:
Unknown on this product.
Ecotoxicity effects:
This product is harmful to aquatic organisms.
Aquatic toxicity effects:
Unknown on product.
Mobility:
Unknown on product.
Persistence / degradability:
Unknown on product.
Bioaccumulation:
Unknown on product.
Degradation:
13. DISPOSAL CONSIDERATIONS
Company: ADVANCED STERLIZATION PRODUCTS Product code: ASPOPA
Product name: CIDEX?OPA Solution CO-12305-2
Page 5 of 7
Waste disposal must be in accordance with appropriate US,
Waste from residues / unused products:
Federal, State and International regulations. This product, if
unaltered by use, may be disposed of by treatment at a
permitted facility or as advised by your local hazardous
waste regulatory authority.
This product is not a hazardous waste as defined by EPA
definitions.
Do not re-use empty containers
Contaminated packaging:
If required, neutralize by sprinkling approximately 25 grams
Methods for cleaning up:
of glycine (CAS # 56-40-6) powder per gallon of CIDEX OPA
Solution spill. Thoroughly blend the glycine into the spill
using mop or other tools. Allow 5 minutes contact for
neutralization. Pick up and transfer to properly labeled
containers. Allow neutralization to continue for 1 hour and
then dispose of in accordance with all applicable federal,
state, and local regulations.
Clean contaminated surface thoroughly.
14. TRANSPORT INFORMATION
DOT:
Not applicable
DOT UN-No:
Not regulated
DOT shipping name:
Not applicable
Hazard class:
Not applicable
Subsidiary risk (hazard class):
Not applicable
Packing group:
Not applicable
DOT reportable quantity (lbs):
IMO/IMDG:
Not applicable
Hazard class:
Not applicable
IMDG page:
Not applicable
IMDG-labels:
Not applicable
Packing group:
Not applicable
MFAG table No.:
Not regulated
Proper shipping name:
Not applicable
UN/Id No.:
ADR/RID:
Not applicable
Hazard class/packing group:
Not applicable
Item:
Not applicable
ADR/RID-labels:
Not applicable
UN/Id No.:
Not regulated
Proper shipping name:
Not applicable
TREM-card:
IATA/ICAO:
Not applicable
Hazard class:
Not applicable
Packing group:
Not regulated
Proper shipping name:
Not applicable
ID/UN No.:
Not applicable
IATA - label:
Not applicable
ERG #
TDG (Canada):
Not applicable
Status:
Not applicable
Packing group:
Company: ADVANCED STERLIZATION PRODUCTS Product code: ASPOPA
Product name: CIDEX?OPA Solution CO-12305-2
Page 6 of 7
15. REGULATORY INFORMATION
SARA (311, 312) hazard class:
None
Immediate health:
None
Delayed health:
None
Fire:
None
Sudden Release of
Pressure Hazard:
None
Reactivity:
Listed under TSCA: Yes
TSCA inventory list:
WHMIS:
None
WHMIS trade secret:
None
WHMIS hazard class:
Listed on DSL: Yes
Canada DSL inventory list:
Notes:
1. SARA = Superfund Amendments and the Reauthorization Act.
2. CERCLA = Comprehensive Environmental Response, Compensations and Liability Act.
3. FIFRA = Federal Insecticide, Fungicide and Rodenticide Act
4. TSCA = Toxic Substance Control Act
5. WHMIS = Canadian Workplace Hazardous Materials Information System
6. This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and
the MSDS contains all of the information required by the CPR.
16. OTHER INFORMATION
This data sheet contains changes from the previous version in section(s):
None
None
Additional advice
None
Literary Reference:
North American Format - U.S. and Canada
MSDS format:
This Material Safety Data Sheet was prepared in accordance with OSHA 29 CFR
1910.1200.
Disclaimer:
The information and recommendations contained herein are based upon tests believed to be reliable. However, Johnson
and Johnson does not guarantee their accuracy or completeness NOR SHALL ANY OF THIS INFORMATION
CONSTITUTE A WARRANTY, WHETHER EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE
MERCHANTABILITY OF THE GOODS, OR THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE.
Adjustment to conform to actual conditions of usage maybe required. Johnson and Johnson assumes no responsibility
for results obtained or for incidental or consequential damages, including lost profits arising from the use of these data.
No warranty against infringement of any patent, copyright or trademark is made or implied.
End of Safety Data Sheet
Company: ADVANCED STERLIZATION PRODUCTS Product code: ASPOPA
Product name: CIDEX?OPA Solution CO-12305-2
Page 7 of 7
|